Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study

被引：0

作者：

Luigi Celio

Diego Cortinovis

Alessio Aligi Cogoni

Luigi Cavanna

Olga Martelli

Simona Carnio

Elena Collovà

Federica Bertolini

Fausto Petrelli

Alessandra Cassano

Rita Chiari

Francesca Zanelli

Salvatore Pisconti

Isabella Vittimberga

Antonietta Letizia

Andrea Misino

Angela Gernone

Erminio Bonizzoni

Sara Pilotto

Sabino De Placido

Emilio Bria

机构：

[1] Desenzano del Garda Hospital,Medical Oncology Unit, ASST del Garda

[2] ASST Monza San Gerardo Hospital,Medical Oncology Department

[3] Azienda Ospedaliero-Universitaria di Sassari,Medical Oncology Department

[4] Azienda Ospedaliera di Piacenza,Oncology Department

[5] ASL Frosinone,Medical Oncology

[6] San Luigi Gonzaga Hospital,Department of Oncology

[7] University of Turin,Cancer Centre Department – Oncology Unit

[8] ASST Ovest Milanese – Legnano Hospital,Department of Oncology and Hematology

[9] AOU Policlinico di Modena,Medical Oncology Unit

[10] ASST Bergamo Ovest,Comprehensive Cancer Center

[11] Fondazione Policlinico Universitario Agostino Gemelli,Medical Oncology

[12] IRCCS,Oncology Unit

[13] Università Cattolica del Sacro Cuore,Medical Oncology Unit

[14] AULSS6 Euganea,Medical Oncology Department

[15] IRCCS Santa Maria Nuova,Department of Oncology

[16] San Giuseppe Moscati Hospital,Department of Pneumology and Oncology

[17] ASST Lecco,Medical Oncology

[18] AORN dei Colli-Ospedale Monaldi,Medical Oncology Unit

[19] Clinical Cancer Center “Giovanni Paolo II” – IRCCS,Department of Clinical Science and Community, Section of Medical Statistics, Biometry and Epidemiology “G.A. Maccacaro”, Faculty of Medicine and Surgery

[20] University of Bari,Section of Oncology, Department of Medicine

[21] Policlinico di Bari,Clinical Medicine and Surgery Department

[22] University of Milan,undefined

[23] University and Hospital Trust of Verona,undefined

[24] University of Naples “Federico II”,undefined

来源：

BMC Cancer | / 22卷

关键词：

Cisplatin; Dexamethasone; NEPA; Quality of life; Functional living index-Emesis; Chemotherapy-induced nausea and vomiting (CINV);

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Miya, Toshimichi
Kobayashi, Kunihiko
Hino, Mitsunori
Ando, Masahiro
Takeuchi, Susumu
Seike, Masahiro
Kubota, Kaoru
Gemma, Akihiko
SPRINGERPLUS, 2016, 5
[32] Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer
Lawrence H. Einhorn
Mary J. Brames
Robert Dreicer
Craig R. Nichols
Michael T. Cullen
Joseph Bubalo
Supportive Care in Cancer, 2007, 15 : 1293 - 1300
[33] Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer
Einhorn, Lawrence H.
Brames, Mary J.
Dreicer, Robert
Nichols, Craig R.
Cullen, Michael T., Jr.
Bubalo, Joseph
SUPPORTIVE CARE IN CANCER, 2007, 15 (11) : 1293 - 1300
[34] NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting (CINV) following repeated chemotherapy cycles: Results of a phase III trial.
Jordan, Karin
Rossi, Giorgia
Rizzi, Giada
Palmas, Marco
Gralla, Richard J.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[35] The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study
Hamada, Shota
Hinotsu, Shiro
Hori, Katsuhito
Furuse, Hiroshi
Oikawa, Takehiro
Kawakami, Junichi
Ozono, Seiichiro
Akaza, Hideyuki
Kawakami, Koji
SUPPORTIVE CARE IN CANCER, 2012, 20 (04) : 813 - 820
[36] The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study
Shota Hamada
Shiro Hinotsu
Katsuhito Hori
Hiroshi Furuse
Takehiro Oikawa
Junichi Kawakami
Seiichiro Ozono
Hideyuki Akaza
Koji Kawakami
Supportive Care in Cancer, 2012, 20 : 813 - 820
[37] A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
Zelek, Laurent
Debourdeau, Philippe
Bourgeois, Hugues
Wagner, Jean Philippe
Brocard, Fabien
Lefeuvre-Plesse, Claudia
Chauffert, Bruno
Leheurteur, Marianne
Bachet, Jean-Baptiste
Simon, Helene
Mayeur, Didier
Scotte, Florian
ONCOLOGIST, 2021, 26 (10): : E1870 - E1879
[38] Phase 3 study of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting during repeated moderately emetogenic chemotherapy (MEC) cycles.
Aapro, Matti S.
Karthaus, Meinolf
Schwartzberg, Lee Steven
Rossi, Giorgia
Rizzi, Giada
Borroni, Maria Elisa
Palmas, Marco
Rugo, Hope S.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[39] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy.
Miya, Toshimichi
Kobayashi, Kunihiko
Hino, Mitsunori
Ando, Masahiro
Takeuchi, Susumu
Seike, Masahiro
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
[40] Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Hesketh, P. J.
Rossi, G.
Rizzi, G.
Palmas, M.
Alyasova, A.
Bondarenko, I.
Lisyanskaya, A.
Gralla, R. J.
ANNALS OF ONCOLOGY, 2014, 25 (07) : 1340 - 1346

← 1 2 3 4 5 →